Tuesday, November 01, 2022 8:04:59 PM
Cell therapies for acute and chronic traumatic brain injury
Masahito Kawabori
, Dai Chida
, Bijan Nejadnik
, Anthony H. Stonehouse
& David O. Okonkwo
Received 01 Jul 2022, Accepted 24 Oct 2022, Accepted author version posted online: 31 Oct 2022
https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2141482
"Traumatic brain injury (TBI) is a global health problem, for which there are no approved therapies. Advances in acute clinical care have improved post-TBI survival, yet many patients are left with chronic TBI-related disabilities (i.e., chronic TBI). Existing treatments which focus on rehabilitation and symptom management do not modify the disease and have limited effectiveness. Consequently, chronic TBI-related disabilities remain a significant unmet medical need. Cell therapies have neuroprotective and neurorestorative effects which are believed to modify the disease."
Confirms as of 24 hrs ago, TBI is still a real problem.
Come on $NDTP lets get it done
Traumatic brain injury (TBI) is a global health problem, affecting more than 50 million people world-wide each year, with direct and indirect costs of treating TBI globally estimated to be US $400 billion per year"
Masahito Kawabori
, Dai Chida
, Bijan Nejadnik
, Anthony H. Stonehouse
& David O. Okonkwo
Received 01 Jul 2022, Accepted 24 Oct 2022, Accepted author version posted online: 31 Oct 2022
https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2141482
"Traumatic brain injury (TBI) is a global health problem, for which there are no approved therapies. Advances in acute clinical care have improved post-TBI survival, yet many patients are left with chronic TBI-related disabilities (i.e., chronic TBI). Existing treatments which focus on rehabilitation and symptom management do not modify the disease and have limited effectiveness. Consequently, chronic TBI-related disabilities remain a significant unmet medical need. Cell therapies have neuroprotective and neurorestorative effects which are believed to modify the disease."
Confirms as of 24 hrs ago, TBI is still a real problem.
Come on $NDTP lets get it done
Traumatic brain injury (TBI) is a global health problem, affecting more than 50 million people world-wide each year, with direct and indirect costs of treating TBI globally estimated to be US $400 billion per year"
Recent NDTP News
- NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion • GlobeNewswire Inc. • 03/03/2026 01:00:00 PM
- NDT Pharmaceuticals Inc.’s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant • GlobeNewswire Inc. • 02/05/2026 02:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog • GlobeNewswire Inc. • 01/14/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s wholly owned subsidiary, Good Salt Life, Inc., Advances into AI-Robotics for Unmanned Hospital Disinfection • GlobeNewswire Inc. • 01/12/2026 01:00:00 PM
- NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant • GlobeNewswire Inc. • 01/08/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals • GlobeNewswire Inc. • 12/19/2025 01:36:01 PM
- Good Salt Life, Inc.'s Induction Charge Delivery Systems Deployed to Protect Show Horses from Widespread EHV-1 Outbreak • ACCESS Newswire • 11/26/2025 01:00:00 PM
- NDT Pharmaceuticals' Subsidiary, Good Salt(TM) Life, Secures Major Government Contract, Deploying Advanced Biosafety Ecosystem in Tennessee State Prisons • ACCESS Newswire • 11/24/2025 02:00:00 PM
- FatPipe, Jackpot Digital, and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 11/07/2025 02:00:00 PM
- 60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 10/31/2025 01:00:00 PM
- Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5 • ACCESS Newswire • 10/30/2025 12:30:00 PM
- NDT Pharmaceuticals Showcases Strategic Value of Good Salt(TM) Life Acquisition with Expanded Relationship with Norwegian Cruise Line • ACCESS Newswire • 10/21/2025 12:30:00 PM
- Baptist Hospital Enhances Patient Safety and Air Quality with Good Salt(TM) Life's ByoCart(TM) Disinfection System • ACCESS Newswire • 10/13/2025 12:30:00 PM
- Good Salt Life Expands EPA Registrations and Anticipates New Milestone • ACCESS Newswire • 10/09/2025 12:30:00 PM
- NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets • ACCESS Newswire • 09/23/2025 01:10:00 PM
